Developed by Alira Health
Oncology Study Landing Page
Powered by
Information About this Study
This is a phase 2 randomized, open-label, active-controlled study evaluating the safety and efficacy of a new cancer medication.
The primary objective of this study is to evaluate the efficacy of a new cancer medication in patients currently diagnosed with this form of cancer.
Who Can Participate
-
18 years and older
Diagnosed with this example cancer.
No allergy to example medicaition.
-
History of prior virologic failure while receiving treatment for example cancer.
Why Should I Participate in this Study?
Cancer continues to be a serious global health issue and can be life-threatening if left untreated. Currently, there is around 17 million people around the world that are diagnosed with cancer each year.
By participating in this study, you will be doing your part in helping develop new treatments for those people.
About the Study App
This study is being conducted using the Health Storylines™ app which can be accessed through your smartphone, mobile device, laptop, personal computer, tablet, or web browser.
How to Participate
To register your interest in participating, please download the Health Storylines™ app using the links underneath to sign up for this study.
You can also scan the following QR code to access the mobile version.
Thank you for your consideration of this important research study.